Eight-year follow-up of a girl with McCune-Albright syndrome

J Clin Res Pediatr Endocrinol. 2011;3(1):40-2. doi: 10.4274/jcrpe.v3i1.09. Epub 2011 Feb 23.

Abstract

McCune-Albright syndrome (MAS) is characterized by the triad of fibrous dysplasia (FD), cafe-au-lait spots and precocious puberty (PP). We report a 14-year-old girl with MAS who has been followed-up for 8 years. She was referred for multiple fractures and vaginal bleeding at age 5.9 years. She had peripheral PP, FD, and osteoporosis and was diagnosed as MAS. The patient was treated with aromatase inhibitors and bisphosphonates. She had no menses during aromatase inhibitor treatment. Her growth rate and bone maturation were in normal ranges while on treatment. She had one new fracture on the seventh year of follow- up in spite of bisphosphonate treatment.

Keywords: McCune-Albright syndrome; aromatase inhibitor; bisphosphonate; follow-up.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Bone Density Conservation Agents / therapeutic use
  • Child
  • Female
  • Fibrous Dysplasia, Polyostotic / diagnosis*
  • Fibrous Dysplasia, Polyostotic / drug therapy
  • Fibrous Dysplasia, Polyostotic / physiopathology*
  • Follow-Up Studies
  • Humans

Substances

  • Bone Density Conservation Agents